000			02172 a2200553 4500
005			20250516053658.0
264		0	_c20111129
008			201111s 0 0 eng d
022			_a1535-5667
024	7		_a10.2967/jnumed.111.091629 _2doi
040			_aNLM _beng _cNLM
100	1		_aBlankenberg, Francis G
245	0	0	_aTargeted systemic radiotherapy with scVEGF/177Lu leads to sustained disruption of the tumor vasculature and intratumoral apoptosis. _h[electronic resource]
260			_bJournal of nuclear medicine : official publication, Society of Nuclear Medicine _cOct 2011
300			_a1630-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aApoptosis _xradiation effects
650	0	4	_aBevacizumab
650	0	4	_aBreast Neoplasms _xblood supply
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival _xradiation effects
650	0	4	_aCombined Modality Therapy
650	0	4	_aEndothelial Cells _xradiation effects
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIndoles _xtherapeutic use
650	0	4	_aLutetium _xpharmacokinetics
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred ICR
650	0	4	_aMice, SCID
650	0	4	_aNeovascularization, Pathologic _xradiotherapy
650	0	4	_aPyrroles _xtherapeutic use
650	0	4	_aRadioisotopes _xpharmacokinetics
650	0	4	_aRadiopharmaceuticals _xpharmacokinetics
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors
650	0	4	_aSunitinib
650	0	4	_aVascular Endothelial Growth Factor A _xpharmacokinetics
700	1		_aLevashova, Zoia
700	1		_aGoris, Michael G
700	1		_aHamby, Carl V
700	1		_aBacker, Marina V
700	1		_aBacker, Joseph M
773	0		_tJournal of nuclear medicine : official publication, Society of Nuclear Medicine _gvol. 52 _gno. 10 _gp. 1630-7
856	4	0	_uhttps://doi.org/10.2967/jnumed.111.091629 _zAvailable from publisher's website
999			_c21132470 _d21132470